| Indicators | Browse All

Biomerica, Inc. (BMRA)

Healthcare | Medical Devices | Irvine, United States | NasdaqCM
1.63 USD -0.06 (-3.550%) ⇩ (July 14, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 5:19 a.m. EDT

The immediate outlook is severely clouded by deteriorating fundamentals and a broken price trend. The company is currently burning cash, with operating cash flow and free cash flow both deeply negative, while profit margins have collapsed to nearly -96%. This financial distress is reflected in the stock's performance, which has suffered a catastrophic 74% decline over the last nine years, despite a recent minor uptick in annual returns. The price action confirms this weakness, trading well below its 50-day and 200-day moving averages, indicating persistent selling pressure. With no analyst recommendations, a lack of dividends, and a balance sheet showing negative returns on equity and assets, there is no compelling case for a near-term bounce or a long-term recovery. The statistical forecast model offers a tiny upside prediction, but its extremely low reliability makes it irrelevant against the backdrop of such profound structural damage.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL_79 ✓0.087961
AutoTheta0.090258
AutoARIMA0.092405
MSTL0.092839
AutoETS0.092995
MSTL_1050.151465
MSTL_79_1050.213148

Forecast horizon: 60 days | Selected: MSTL_79

Forecast Reliability
Score 28%
H-stat 26.13
Ljung-Box p 0.000
Jarque-Bera p 0.072
Excess Kurtosis -0.91
Attribute Value
Sector Healthcare
Debt to Equity Ratio 5.819
Revenue per Share 1.608
Market Cap 5,037,138
Forward P/E 4.18
Beta 0.33
Profit Margins -96.46%
Website https://www.biomerica.com

Info Dump

Attribute Value
52 Week Change -0.44407892
Address1 17,571 Von Karman Avenue
All Time High 187.12
All Time Low 1.36
Ask 2.13
Ask Size 2
Average Daily Volume10 Day 6,360
Average Daily Volume3 Month 17,113
Average Volume 17,113
Average Volume10Days 6,360
Beta 0.332
Bid 1.23
Bid Size 2
Book Value 1.095
City Irvine
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.63
Current Ratio 2.641
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 1.7
Day Low 1.63
Debt To Equity 5.819
Display Name Biomerica
Earnings Timestamp End 1,756,756,800
Earnings Timestamp Start 1,756,238,400
Ebitda -5,268,000
Ebitda Margins -1.21747
Enterprise To Ebitda -0.739
Enterprise To Revenue 0.9
Enterprise Value 3,894,138
Eps Forward 0.39
Eps Trailing Twelve Months -1.61
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 949 553 1231
Fifty Day Average 2.071
Fifty Day Average Change -0.4410001
Fifty Day Average Change Percent -0.21294065
Fifty Two Week Change Percent -44.40789
Fifty Two Week High 4.6
Fifty Two Week High Change -2.9699998
Fifty Two Week High Change Percent -0.6456521
Fifty Two Week Low 1.63
Fifty Two Week Low Change 0.0
Fifty Two Week Low Change Percent 0.0
Fifty Two Week Range 1.63 - 4.6
Financial Currency USD
First Trade Date Milliseconds 463,411,800,000
Float Shares 2,774,011
Forward Eps 0.39
Forward P E 4.179487
Free Cashflow -2,028,375
Full Exchange Name NasdaqCM
Full Time Employees 53
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.04368
Gross Profits 189,000
Has Pre Post Market Data 1
Held Percent Insiders 0.15239
Held Percent Institutions 0.03616
Implied Shares Outstanding 3,090,269
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ir Website http://www.biomerica.com/company/investor.asp
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,748,649,600
Last Split Date 1,745,193,600
Last Split Factor 1:8
Long Business Summary Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Long Name Biomerica, Inc.
Market us_market
Market Cap 5,037,138
Market State PRE
Max Age 86,400
Message Board Id finmb_254941
Most Recent Quarter 1,772,236,800
Net Income To Common -4,174,000
Next Fiscal Year End 1,780,185,600
Non Diluted Market Cap 5,160,749
Open 1.7
Operating Cashflow -3,170,000
Operating Margins -1.3151
Payout Ratio 0.0
Phone 949 645 2111
Pre Market Change -0.00999999
Pre Market Change Percent -0.6097555
Pre Market Price 1.63
Pre Market Time 1,784,103,760
Previous Close 1.69
Price Hint 4
Price To Book 1.4885844
Price To Sales Trailing12 Months 1.1641178
Profit Margins -0.96463996
Quick Ratio 1.459
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.060000062
Regular Market Change Percent -3.5502992
Regular Market Day High 1.7
Regular Market Day Low 1.63
Regular Market Day Range 1.63 - 1.7
Regular Market Open 1.7
Regular Market Previous Close 1.69
Regular Market Price 1.63
Regular Market Time 1,784,059,200
Regular Market Volume 3,786
Return On Assets -0.54584
Return On Equity -0.94317
Revenue Growth -0.118
Revenue Per Share 1.608
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 3,090,269
Shares Percent Shares Out 0.0106
Shares Short 32,611
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 79,979
Short Name Biomerica, Inc.
Short Percent Of Float 0.0119
Short Ratio 1.69
Source Interval 15
State CA
Symbol BMRA
Total Cash 1,336,000
Total Cash Per Share 0.432
Total Debt 193,000
Total Revenue 4,327,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.61
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.33475
Two Hundred Day Average Change -0.70474994
Two Hundred Day Average Change Percent -0.30185243
Type Disp Equity
Volume 3,786
Website https://www.biomerica.com
Zip 92,614